TGA approves Aussie-made flu vax

Australia’s only locally manufactured, quadrivalent seasonal influenza vaccine (QIV) has received Therapeutic Goods Administration (TGA) approval.

Afluria Quad, Seqirus’ four-strain, inactivated seasonal influenza vaccine, is indicated for people aged 18 years and older. It will replace the company’s trivalent vaccine (TIV), Fluvax for the 2017 flu season.

Manufactured in Parkville, Melbourne, Afluria Quad will be supplied locally and exported globally.